The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck

  • Ju Pi Li
  • , Chia Yu Yang
  • , Huai Chia Chuang
  • , Joung Liang Lan
  • , Der Yuan Chen
  • , Yi Ming Chen
  • , Xiaohong Wang
  • , Alice J. Chen
  • , John W. Belmont
  • , Tse Hua Tan*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

123 Scopus citations

Abstract

JNK pathway-associated phosphatase (JKAP, also known as DUSP22 or JSP-1) is a JNK activator. The in vivo role of JKAP in immune regulation remains unclear. Here we report that JKAP directly inactivates Lck by dephosphorylating tyrosine-394 residue during T-cell receptor (TCR) signalling. JKAP-knockout T cells display enhanced cell proliferation and cytokine production. JKAP-knockout mice show enhanced T-cell-mediated immune responses and are more susceptible to experimental autoimmune encephalomyelitis (EAE). In addition, the recipient mice that are adoptively transferred with JKAP-knockout T cells show exacerbated EAE symptoms. Aged JKAP-knockout mice spontaneously develop inflammation and autoimmunity. Thus, our results indicate that JKAP is an important phosphatase that inactivates Lck in the TCR signalling turn-off stage, leading to suppression of T-cell-mediated immunity and autoimmunity.

Original languageEnglish
Article number3618
JournalNature Communications
Volume5
DOIs
StatePublished - 09 04 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck'. Together they form a unique fingerprint.

Cite this